Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

	News, Updates and Commentary
	News RSS Feed

Free Newsletter

We value your privacy. We will not rent your email to anyone.

HEPATITIS NEWS

Genelabs, Taiwan company collaborate on hepatitis C research
Redwood City-based Genelabs (NASDAQ:GNLB) said the agreement includes the , a nonprofit foundation established by the government of the Republic of China, and Ltd., a biopharmaceutical company in Taiwan. Financial details were not disclosed. In June

Judge OKs emotional distress in hepatitis case
LAS VEGAS (AP) - A Nevada judge says patients who weren't made ill can claim emotional distress in a class-action lawsuit alleging a Las Vegas medical clinic exposed them to hepatitis by reusing syringes and vials of medication. Clark County District

Genelabs, China companies collaborate on hepatitis C research
Extract not available.

UPDATES AND COMMENTARY

Natalie Cole Optimistic About Her Battle with Hepatitis C
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus....

Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....

Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...

Ribavirin/Rebetron

Ribavirin Treatment of HCV	Ribavirin approved for combo treatment
Ribavirin Interferon Combination with phlebotomy	What is Rebetron? (Facts)
IFN Alfa-2b Plus Ribavirin Combination Increases Sustained Response Rate	Ribavirin Treatment alone or in combination with Interferon
Phase III results of Interferon & Rebetol	FDA approves Rebetron Combination Therapy
Long term efficacy of Ribavirin plus interferon alfa	Interferon, Ribavirin and Actigall
Hepatitis C: Important Treatment Advance: Interview with Douglas Dieterich, MD	Schering Submits Supplemental NDA for REBETRON(TM)
Ribavirin Info Sheet	New Therapy Packs Powerful One-Two Punch Against HCV
A randomized study comparing ribavirin and interferon alfa monotherapy for Hepatitis C recurrence after liver transplantation	Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover
Rebetol(TM) Plus Intron (Interferon)A	Treatment response in chronic Hepatitis C. Content of virus in serum is decisive for the outcome
Effect of ribavirin on virus load and quasispecies distribution in patients infected with Hepatitis C virus	Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic Hepatitis C not responding to interferon alone
Ribavirin monotherapy in patients with chronic Hepatitis C	Ribavirin in Hepatitis C related cryoglobulinemia
Adding ribavirin to interferon alpha-2b for chronic Hepatitis C infection increased virological response and nausea	Interferon alpha with ribavirin for the treatment of chronic Hepatitis C in non-responders or relapsers to interferon monotherapy
Effects of the ribavirin-interferon alpha combination on cultured peripheral blood mononuclear cells from chronic Hepatitis C patients	Hepatitis C Virus Dynamics In Vivo: Effect of Ribavirin and Interferon Alfa on Viral Turnover
Schering-Plough Reports Results of Clinical Studies of REBETRON(TM) Combination Therapy for Hepatitis C at American Association for the Study of Liver Diseases Meeting	Two Drugs Are Better for Hepatitis
Studies Show Significant Increase in Rate of Sustained Response With Combination Therapy as Compared to Standard Treatment	Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C
r-Interferon Alfa-2b/Ribavirin Combined Therapy Followed by Low-Dose r-Interferon Alfa-2b in Chronic Hepatitis C Interferon Nonresponders	New Warnings Placed On Rebetron Hepatitis Therapy
Quantification of Serum Hepatitis C Virus RNA	Rebetron Safety Information

Table of Contents

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Search Site

Topics

Ribavirin/Rebetron